These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9636524)

  • 21. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract]   [Full Text] [Related]  

  • 22. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
    Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
    Transplant Proc; 1997; 29(1-2):334-6. PubMed ID: 9123027
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring azathioprine therapy in pediatric renal transplant patients with red blood cell thiopurine methyltransferase.
    Dervieux T; Médard Y; Baudouin V; Maisin A; Zhang D; Loirat C; Jacqz-Aigrain E
    Transplant Proc; 2000 Mar; 32(2):361-3. PubMed ID: 10715440
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of immunosuppressive induction regimens in renal transplantation. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1998 Dec; 30(8):4029-30. PubMed ID: 9865286
    [No Abstract]   [Full Text] [Related]  

  • 26. Tacrolimus for rescue therapy in refractory renal allograft rejection.
    Jang HJ; Kim SC; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1765-6. PubMed ID: 11119925
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
    Lye WC
    Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
    Artz MA; Boots JM; Ligtenberg G; Roodnat JI; Christiaans MH; Hené RJ; Blom HJ; Demacker PN; Hilbrands LB
    Transplant Proc; 2002 Aug; 34(5):1793-4. PubMed ID: 12176579
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunosuppressive therapy without calcineurin inhibitors for renal transplants? Perhaps we should be cautions...].
    Fasoli G
    G Ital Nefrol; 2007; 24(2):110. PubMed ID: 17458825
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
    Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract]   [Full Text] [Related]  

  • 31. Does cyclosporine influence the outcome in patients with acute tubular necrosis after renal transplantation.
    Ritz M; Botha J; Pontin AR; Pascoe MD; Kahn D
    Transplant Proc; 1999; 31(1-2):303. PubMed ID: 10083117
    [No Abstract]   [Full Text] [Related]  

  • 32. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H;
    Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
    Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE
    Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract]   [Full Text] [Related]  

  • 35. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
    Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
    Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of lipoprotein A in renal transplant recipients.
    Innocenti M; Lorenzetti M; Naldi F; Paleologo G; Pasquariello A; Marchetti P; Giannarelli R; Rindi P; Navalesi R; Rizzo G
    Transplant Proc; 1998 Aug; 30(5):2048. PubMed ID: 9723386
    [No Abstract]   [Full Text] [Related]  

  • 37. Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine.
    Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
    Transplant Proc; 1999; 31(1-2):744-5. PubMed ID: 10083317
    [No Abstract]   [Full Text] [Related]  

  • 38. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas CA; Jain A; Hakala TR; McCauley J; Johnston J; Randhawa P; Fedorek S; Gray E; Chesky A; Dvorchik I; Donaldson J; Fung JJ; Starzl TE
    Transplant Proc; 2002 Aug; 34(5):1651-2. PubMed ID: 12176521
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center.
    Ushigome H; Okamoto M; Kadotani Y; Nakamura K; Akioka K; Ohmori Y; Yoshimura N
    Transplant Proc; 2002 Aug; 34(5):1681-2. PubMed ID: 12176533
    [No Abstract]   [Full Text] [Related]  

  • 40. Conversion of cyclosporine to azathroprine in renal transplant recipients.
    Bassiri A; Amiranssari B; Gol S
    Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.